No evidence that CD33 splicing SNP impacts the response to GO in younger adults with AML treated on UK MRC/NCRI trials

Gale, Rosemary E., Popa, Teodora, Wright, Melissa, Khan, Naeem, Freeman, Sylvie D., Burnett, Alan K., Russell, Nigel H., Hills, Robert and Linch, David C. 2018. No evidence that CD33 splicing SNP impacts the response to GO in younger adults with AML treated on UK MRC/NCRI trials. Blood 131 (4) , pp. 468-471. 10.1182/blood-2017-08-802157

Preview

PDF - Accepted Post-Print Version Download (631kB) | Preview

Item Type:	Article
Date Type:	Published Online
Status:	Published
Schools:	Medicine Centre for Trials Research (CNTRR)
Publisher:	American Society of Hematology
ISSN:	0006-4971
Date of First Compliant Deposit:	13 June 2018
Date of Acceptance:	1 December 2017
Last Modified:	25 Nov 2020 02:34
URI:	http://orca.cf.ac.uk/id/eprint/112239

Citation Data

Cited 16 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item